This study critically assessed the published clinical and economic evidence supporting oncology orphan drugs marketed in the United States.
Brian W. Bresnahan, PhD
Advertisement
Articles by Brian W. Bresnahan, PhD
Advertisement
Latest Updated Articles
- Systematic Review of Comparative Effectiveness Data for Oncology Orphan Drugs
Published: January 19th 2012 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
2
In Primary Care–Oncology Collaboration, the Baton Goes Both Ways
3
FDA Expands Evinacumab-dgnb Approval for Children as Young as 1 Year With HoFH
4
Marathon Health, Medbridge Partner to Launch Integrated Virtual MSK Care Program
5
